Immunotherapy By Cancer Type

Immunotherapy: Impacting All Cancers

Immunotherapy is a form of cancer treatment that uses the power of the body’s immune system to prevent, control, and eliminate cancer. From the preventive vaccine for cervical and liver cancer to the first therapy ever proven to extend the lives of patients with metastatic melanoma, immunology has already led to major treatment breakthroughs for a number of cancers. Every cancer type is unique, though, and immunology and immunotherapy are impacting each cancer in different ways.

Explore immunotherapies by cancer type and explore different kinds of treatment, why immunotherapy matters, and how to support cancer immunotherapy research.

Bladder cancer location illustration

Bladder Cancer

The first FDA-approved immunotherapy treatment—Bacillus Calmette-Guérin cancer vaccine—was for bladder cancer in 1990.
Brain cancer location illustration

Brain Cancer

Cancers of the brain and nervous system are relatively rare but very serious. Immunotherapy is showing significant promise.
Breast cancer location illustration

Breast Cancer

New breast cancer immunotherapy treatments have shown great promise, with the potential for long-term success.
Cervical cancer location illustration

Cervical Cancer

Three preventive cancer vaccines are already helping to stop cervical cancer, with new clinical trials now available to patients.
Childhood cancer location illustration

Childhood Cancer

Immunotherapy offers a potential way to treat childhood (pediatric) cancer without the damaging, long-term side effects of conventional treatments.
Colorectal cancer location illustration

Colorectal Cancer

There are several FDA-approved immunotherapies for colorectal cancer, for which patients are in urgent need of new treatment options.
Esophageal cancer location illustration

Esophageal Cancer

Immunotherapy for esophageal cancer is being explored to reduce recurrence as a first-line treatment option.
Immunotherapy for head and neck cancer

Head and Neck Cancer

Immunotherapy offers treatment options for patients with cancers of the mouth, throat, voice box, sinuses, nose, and salivary glands.
immunotherapy for kidney cancer

Kidney Cancer

Immunotherapy for kidney cancer—also called renal cell cancer—has tremendously changed the overall survival of patients.
Immunotherapy for Leukemia


There are several FDA-approved immunotherapies for leukemia (leukaemia) and ongoing research demonstrates even greater potential for new treatments.
immunotherapy for liver cancer

Liver Cancer

In addition to the first FDA-approved hepatitis B cancer vaccine, immunotherapy increases the immune response to liver cancer.
immunotherapy for lung cancer illustration

Lung Cancer

Immunotherapy is a promising option for advanced lung cancer, alone or in combination with treatments like chemotherapy or surgery.
immunotherapy for lymphoma illustration


Several FDA-approved immunotherapies offer treatment options to children and adults with Hodgkin and non-Hodgkin lymphoma.
Immunotherapy for melanoma illustration


Immunotherapy has changed the way melanoma is treated. In particular, checkpoint inhibitors are responsible for the increasing survival rate…
Immunotherapy For Multiple Myeloma location illustration

Multiple Myeloma

Immunotherapy for multiple myeloma is a promising new treatment option, with the potential to result in long-term cancer remission…
Immunotherapy For Ovarian Cancer location illustration

Ovarian Cancer

Research into immunotherapy for ovarian cancer is promising, especially since more treatment options for patients and oncologists are urgently…
immunotherapy for pancreatic cancer location illustration

Pancreatic Cancer

Pancreatic cancer has few treatment options, so pancreatic cancer immunotherapy research is vital to providing patients with new hope.
immunotherapy for prostate cancer location illustration

Prostate Cancer

With a cancer vaccine and checkpoint inhibitor already approved, immunotherapy research offers new hope to patients with advanced prostate…
Immunotherapy for sarcoma location illustration


Immunotherapy for sarcoma has some success cases, including the earliest known instances of spontaneous regression, although sarcoma cancer immunology…
immunotherapy for skin cancer location illustration

Skin Cancer

Skin cancers are common, often diagnosed at an early stage, and among the first cancers to respond to immunotherapy.
immunotherapy for stomach cancer location illustration

Stomach Cancer

Immunotherapies, including checkpoint inhibitors and targeted antibodies, offer promising new treatment options for stomach (gastric) cancer patients.
Immunotherapy for uterine cancer location illustration

Uterine (Endometrial) Cancer

Immunotherapy for uterine (endometrial) cancer is an emerging area of research and treatment, especially for patients with advanced cases….

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.